title: Cyclosporin A toxicity, and more: vascular endothelial growth factor (VEGF) steps forward.
authors.forename: Carlos
authors.initials: C
authors.lastname: Caramelo
authors.forename: M Victoria
authors.initials: MV
authors.lastname: Alvarez-Arroyo
authors.forename: Susana
authors.initials: S
authors.lastname: Yagüe
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Suzuki
authors.forename: M Angeles
authors.initials: MA
authors.lastname: Castilla
authors.forename: Lara
authors.initials: L
authors.lastname: Velasco
authors.forename: F Roman
authors.initials: FR
authors.lastname: Gonzalez-Pacheco
authors.forename: Alberto
authors.initials: A
authors.lastname: Tejedor
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology* / Q000633:toxicity*; D019610:Cytoprotection / Q000187:drug effects* / Q000502:physiology; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects; D006801:Humans; D007683:Kidney Tubular Necrosis, Acute / Q000188:drug therapy / Q000517:prevention & control*; D007684:Kidney Tubules / Q000166:cytology / Q000502:physiology; D012680:Sensitivity and Specificity; D042442:Vascular Endothelial Growth Factors / Q000187:drug effects / Q000378:metabolism*
chemical_list: D042442:Vascular Endothelial Growth Factors; D016572:Cyclosporine